KBI Biopharma has created a platform E.coli resulting in a PURE, efficient platform expression strain - PUREcoli ™ - to reduce impurities and reach higher titers.
KBI Biopharma
Advertisement
Articles by KBI Biopharma
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know About Pharmaceutical Tariffs in 2025
2
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Challenges for the Global Manufacturing of Vaccines
5
